Request Demo
Last update 04 Mar 2026
SENL-103
Last update 04 Mar 2026
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms S 103, S-103(Hebei Senlangbio Biotechnology ), S103 + [2] |
Target |
Action modulators |
Mechanism BCMA modulators(B-cell maturation protein modulators), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with SENL-103ChiCTR2500112137
An open-label, single-arm Phase I clinical study of SENL103 autologous T-cell injection (S103) for the treatment of refractory generalized myasthenia gravis
NCT06067581
Clinical Study on the Safety and Efficacy of SENL103 Autologous T Cell Injection in the Treatment of Recurrent or Refractory Plasma Cell Blood Tumors
CTR20254843
SENL103自体T细胞注射液（S103）治疗复发或难治性多发性骨髓瘤受试者安全性和有效性的多中心、开放、单臂的I/II期临床研究
[Translation] A multicenter, open-label, single-arm phase I/II clinical study of the safety and efficacy of SENL103 autologous T-cell injection (S103) in treating relapsed or refractory multiple myeloma.
100 Clinical Results associated with SENL-103
Login to view more data
100 Translational Medicine associated with SENL-103
Login to view more data
100 Patents (Medical) associated with SENL-103
Login to view more data
100 Deals associated with SENL-103
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Refractory Multiple Myeloma | Phase 2 | - | 01 Feb 2026 | |
| Relapse multiple myeloma | Phase 2 | - | 01 Feb 2026 | |
| Multiple Myeloma | Phase 2 | China | 12 Dec 2025 | |
| Myasthenia Gravis | Phase 1 | China | 16 Oct 2025 | |
| Systemic Lupus Erythematosus | Clinical | China | - | |
| Immunoglobulin Light-Chain Amyloidosis | IND Approval | China | 02 Feb 2026 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free